3Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J].Clin Infect Dis,2007,44(Suppl 2):S27-72.
6McMahon LF Jr,Wolfe RA,Tedeschi PJ.Variation in hospital admission among smallareas:a comparison of Maine and Michigan[J].Med Care,1989,27(6):623-631.
7Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia[J].N Engl J Med,1997,336(4):243-250.
8Lim WS,van der Eerden MM,Liang R,et al.Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study[J].Thorax,2003,58(5):377-382.
9Sokolove PE,Mackey D,Wiles J,et al.Exposure of emergency department personnel to tuberculosis:PPD testing during an epidemic in the community[J].Ann Emerg Med,1994,24(3):418-421.
10Centers for Disease Control and Prevention.Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities,1994[J].MMWR Recomm Rep,1994,43(RR-13):1-132.
4Haley RW, Culver DH, White JW, et al. The nation-wide injection rate. A new need for vital statistics[J], Am J Epidemial,1985,121:159-167.
5Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
7Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
8Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
9Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
10Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
1Ginsberq MD, Palech YY, Hill MD, et al. High - dose albumin treat- ment for acute ischaemic stroke ( ALIAS ) , Part2 : a randomised, dou- bleblind,phase 3 ,placebo - controlled trial[ J]. Lancet Neurol,2013, 12(11) :1049 -1058.
2Patel A,Laffan MA,Waheed U,et al. Randomised trials of human al- bumin for aduhs with sepsis: systematic review and meta - analysis with trial sequential analysis of all -cause mortality [ J]. BMJ,2014,22(349) :g4561.
3Fine MJ,Smith MA,Carson CA,et al. Prognosis and outcomes of pa- tients with community - acguired pneumonia. A meta - analysis [ J ]. JAMA,1996,275(2) :134 - 141.
4Caironi P, Toqnoni G, Gattinoni L. Albumin replacement in severe sepsis or septic shock[ J]. N Engl J,2014,371 ( 1 ) :84.
5Jiang L,Jiang S,Zhang Z, et al. Albumin versos other fluids for fluid resuscitation in patients with sepsis : a meta - analysis [ J ]. PLoS One, 2014,9(12) :e114666.
